Shuttle Pharmaceuticals, Inc.
1 clinical trials · Sponsor
◉ Watch Shuttle Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter (NCT06359379) | Shuttle Pharmaceuticals, Inc. | 2024-09-02 |
Track Shuttle Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.